These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 30446206)
1. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder. Smith AM; King JJ; West PR; Ludwig MA; Donley ELR; Burrier RE; Amaral DG Biol Psychiatry; 2019 Feb; 85(4):345-354. PubMed ID: 30446206 [TBL] [Abstract][Full Text] [Related]
2. A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project. Smith AM; Natowicz MR; Braas D; Ludwig MA; Ney DM; Donley ELR; Burrier RE; Amaral DG Autism Res; 2020 Aug; 13(8):1270-1285. PubMed ID: 32558271 [TBL] [Abstract][Full Text] [Related]
3. Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China. Zou M; Li D; Wang L; Li L; Xie S; Liu Y; Xia W; Sun C; Wu L Neurotox Res; 2020 Dec; 38(4):992-1000. PubMed ID: 32719995 [TBL] [Abstract][Full Text] [Related]
4. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. West PR; Amaral DG; Bais P; Smith AM; Egnash LA; Ross ME; Palmer JA; Fontaine BR; Conard KR; Corbett BA; Cezar GG; Donley EL; Burrier RE PLoS One; 2014; 9(11):e112445. PubMed ID: 25380056 [TBL] [Abstract][Full Text] [Related]
5. Maternal Obesity/Diabetes, Plasma Branched-Chain Amino Acids, and Autism Spectrum Disorder Risk in Urban Low-Income Children: Evidence of Sex Difference. Panjwani AA; Ji Y; Fahey JW; Palmer A; Wang G; Hong X; Zuckerman B; Wang X Autism Res; 2019 Oct; 12(10):1562-1573. PubMed ID: 31400063 [TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study. Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215 [TBL] [Abstract][Full Text] [Related]
7. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Gevi F; Zolla L; Gabriele S; Persico AM Mol Autism; 2016; 7():47. PubMed ID: 27904735 [TBL] [Abstract][Full Text] [Related]
8. The Association Between Branched-Chain Amino Acid Concentrations and the Risk of Autism Spectrum Disorder in Preschool-Aged Children. Gao Q; Bi D; Li B; Ni M; Pang D; Li X; Zhang X; Xu Y; Zhao Q; Zhu C Mol Neurobiol; 2024 Aug; 61(8):6031-6044. PubMed ID: 38265552 [TBL] [Abstract][Full Text] [Related]
9. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647 [TBL] [Abstract][Full Text] [Related]
10. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder. Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128 [TBL] [Abstract][Full Text] [Related]
11. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children. Lv QQ; You C; Zou XB; Deng HZ Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069 [TBL] [Abstract][Full Text] [Related]
13. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder. Yui K; Tanuma N; Yamada H; Kawasaki Y Int J Dev Neurosci; 2017 Aug; 60():70-77. PubMed ID: 27554135 [TBL] [Abstract][Full Text] [Related]
14. Lower circulating endocannabinoid levels in children with autism spectrum disorder. Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J Mol Autism; 2019; 10():2. PubMed ID: 30728928 [TBL] [Abstract][Full Text] [Related]
15. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction. Usui N; Iwata K; Miyachi T; Takagai S; Wakusawa K; Nara T; Tsuchiya KJ; Matsumoto K; Kurita D; Kameno Y; Wakuda T; Takebayashi K; Iwata Y; Fujioka T; Hirai T; Toyoshima M; Ohnishi T; Toyota T; Maekawa M; Yoshikawa T; Maekawa M; Nakamura K; Tsujii M; Sugiyama T; Mori N; Matsuzaki H EBioMedicine; 2020 Aug; 58():102917. PubMed ID: 32739868 [TBL] [Abstract][Full Text] [Related]
16. Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites. Mussap M; Noto A; Fanos V Expert Rev Mol Diagn; 2016 Aug; 16(8):869-81. PubMed ID: 27310602 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation. Melamed IR; Heffron M; Testori A; Lipe K Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532 [TBL] [Abstract][Full Text] [Related]
18. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder. Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522 [TBL] [Abstract][Full Text] [Related]
19. Reduction of essential amino acid levels and sex-specific alterations in serum amino acid concentration profiles in children with autism spectrum disorder. Yu X; Qian-Qian L; Cong Y; Xiao-Bing Z; Hong-Zhu D Psychiatry Res; 2021 Mar; 297():113675. PubMed ID: 33444991 [TBL] [Abstract][Full Text] [Related]
20. Altered Metabolic Characteristics in Plasma of Young Boys with Autism Spectrum Disorder. Wang L; Zheng R; Xu Y; Zhou Z; Guan P; Wu Y; Zhou J; Cheng Z; Zhang L J Autism Dev Disord; 2022 Nov; 52(11):4897-4907. PubMed ID: 34800227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]